Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma treatment is generally safe and effective for hair loss, acne scars, skin discoloration, and facial rejuvenation, but deeper injections are better and multiple treatments can increase risk of side effects.

SLE in ageing patients is less severe and needs careful treatment to avoid excess.

Men face more severe COVID-19 outcomes, while women are more likely to have long-term symptoms.

Clinical trials for alopecia areata need better inclusion and retention of patients of color.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

Combination therapy for 9+ months maintains symptom improvements after stopping alpha-blockers or finasteride.

Combination therapy is better for long-term control and outcomes in type 2 diabetes.

Long COVID recovery is hindered by smoking, with hair loss being a difficult symptom to treat.

Non-Kuwaitis with COVID-19 had higher chances of severe outcomes than Kuwaitis.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Skin reactions from cancer treatments might predict how well the treatments work.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

High-dose UVA-1 therapy improves symptoms and skin condition in sclerosing skin disease.

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

Canakinumab's effect on COVID-19 outcomes is unclear.

GT20029 showed some hair growth improvement, but longer studies are needed for better results.

Current treatments for alopecia areata often fail to achieve and maintain significant hair regrowth.

Nutritional education reduces chemotherapy side effects and improves health in breast cancer patients.

PRP treatment effectively improves hair density and thickness in people with androgenic alopecia.

Three patients suffered severe health issues due to not getting enough vitamins and minerals after weight-loss surgery.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Non-blinded assessors tend to overestimate effects in trials by about 29%.

Microneedling with CGF significantly improves hair regrowth in androgenetic alopecia.

Artificial intelligence can accurately predict hair growth and treatment results in female pattern hair loss patients, with age of onset and duration being key factors.

Baseline severity, disease activity, and relapse history are key to predicting response and recurrence in alopecia areata.

Patients with skin cancer on the scalp and ear in Mexico have specific features and results from their treatments.